Table 4.

One way sensitivity analysis (rash subgroup)

Parameter	Variation (%)	ICER (£)
Base case		56 768
Erlotinib cost	−20	45 821
	+20	67 530
Radiotherapy costs	−20	56 823
	+20	55 953
Hospital admission costs	−20	54 018
	+20	58 758
Preprogression utility	−20	97 671
	+20	48 945
Postprogression utility	−20	160 019
	+20	49 845
Missing data adjustments*	–	<58 400

*Using multiple imputation.